MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery ROA Ratio 2011-2026 | APEN
Annual ROA Ratio Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.14 | -18.77 | -29.2 | -36.78 | -61.49 | -25.02 | -40.31 | -86.2 | -78.99 | -41.89 | -10.13 | -17.36 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.13 | -86.2 | -40.19 |
Quarterly ROA Ratio Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23.33 | -32.69 | -25.46 | -29.52 | -19.64 | -22.99 | -16.98 | -21.0 | -24.67 | -36.28 | -44.54 | -48.23 | -35.14 | -48.24 | -49.74 | -50.79 | -36.84 | -41.33 | -32.72 | -26.2 | -18.32 | -24.13 | -25.44 | -28.47 | -21.01 | -40.18 | -53.55 | -67.23 | -66.05 | -81.17 | -77.11 | -71.89 | -48.65 | -64.79 | -65.81 | -56.85 | -32.94 | -36.99 | -24.9 | -18.46 | -4.05 | 2.24 | 12.6 | 22.62 | 4.76 | 6.3 | 7.65 | -9.18 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 22.62 | -81.17 | -32.24 |
ROA Ratio of other stocks in the Medical devices industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-86.71 | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-8.34 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
-53.67 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
1.95 | $ 39.37 | 0.24 % | $ 5.87 K | USA |
 |
Lianluo Smart Limited
LLIT
|
-53.6 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
-11.45 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-16.53 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-116.17 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
-151.34 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-70.61 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-119.24 | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-2.42 | $ 8.02 | 2.56 % | $ 576 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
-9.84 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-56.51 | - | -0.97 % | $ 54.4 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-22.1 | $ 4.17 | 4.51 % | $ 155 M |  France |
 |
AdaptHealth Corp.
AHCO
|
-1.64 | $ 9.72 | 3.4 % | $ 1.31 B | USA |
 |
FONAR Corporation
FONR
|
6.24 | $ 18.55 | 0.27 % | $ 122 M | USA |
 |
CONMED Corporation
CNMD
|
2.02 | $ 43.46 | 0.12 % | $ 1.35 B | USA |
 |
Electromed
ELMD
|
14.01 | $ 23.79 | -0.56 % | $ 201 M | USA |
 |
CryoLife, Inc.
CRY
|
-2.11 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-133.04 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
-323.35 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
-7.08 | $ 29.86 | 0.1 % | $ 1.38 B | USA |
 |
Apyx Medical Corporation
APYX
|
-23.62 | $ 3.28 | 3.48 % | $ 114 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-9.05 | - | - | $ 3.31 B | USA |
 |
InMode Ltd.
INMD
|
12.24 | $ 13.51 | -0.66 % | $ 873 M | Israel |
 |
IRIDEX Corporation
IRIX
|
-27.79 | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
IRadimed Corporation
IRMD
|
19.56 | $ 106.1 | 1.74 % | $ 1.34 B | USA |
 |
Soliton, Inc.
SOLY
|
-43.02 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-86.69 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-17.05 | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
-0.34 | $ 0.52 | -0.89 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
-8.55 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-37.58 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
6.77 | - | 10.28 % | $ 55.5 M | Israel |
 |
LivaNova PLC
LIVN
|
-9.3 | $ 68.02 | -0.6 % | $ 3.71 B |  Britain |
 |
Cytosorbents Corporation
CTSO
|
-43.74 | $ 0.79 | -1.52 % | $ 43 M | USA |
 |
Pulmonx Corporation
LUNG
|
-34.63 | $ 1.5 | -2.29 % | $ 58.7 M | USA |
 |
Align Technology
ALGN
|
6.78 | $ 182.98 | 0.19 % | $ 13.7 B | USA |
 |
Medtronic PLC
MDT
|
5.09 | $ 96.27 | -0.48 % | $ 124 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-31.81 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
-5.81 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-28.31 | $ 3.92 | 6.52 % | $ 830 M | USA |
 |
BIOLASE
BIOL
|
-58.78 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
7.52 | $ 113.6 | -0.01 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
1.82 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-20.48 | - | - | $ 217 M | USA |
 |
BioSig Technologies
BSGM
|
-1226.84 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
6.62 | $ 72.51 | -1.81 % | $ 107 B | USA |